Arthritis

Providing you the best range of exemptia 40 mg adalimumab injection, methotrexate tablet, tofacitinib 5 mg tablets and betrecep 5 mg with effective & timely delivery.

Exemptia 40 Mg Adalimumab Injection

Request Callback

₹ 9999 Get Latest Price

BrandExemptia
Strength / Dose40 mg / 0.8 ml
ManufacturerZydus
Packaging TypePre Filled Syringe
Packaging Size1 ml
CompositionAdalimumab (40mg/0.8ml)
UsageRheumatoid arthritis
Exemptia 40mg/0.8ml Injection is a medicine used to treat a variety of conditions such as ankylosing spondylitis, rheumatoid arthritis, psoriasis, ulcerative colitis, and Crohn’s disease. It provides relief from swelling, pain, and redness associated with various disorders and improves physical function.

Methotrexate Tablet

Request Callback

₹ 35 Get Latest Price

Strength / Dose2.5mg
BrandMethocel
Packaging Size1x10
CompositionMethotrexate
TreatmentRheumatoid arthritis, Psoriasis
ManufacturerCelon
FormTablet
Country of OriginMade in India
Methocel 2.5mg Tablet is a medicine used to treat rheumatoid arthritis where it helps prevent further joint damage. It is also used to treat severe forms of a skin disease called psoriasis where it works by killing cells in the skin that grow too quickly.

Tofacitinib 5 Mg Tablets

Request Callback

₹ 299 Get Latest Price

BrandJaknat
ManufacturerNatco Pharma Ltd
Strength5 mg
Packaging Size1*10 Tablets
Packaging TypeStrips
CompositionTofacitinib 5mg
Tfct-Nib Tablet is used to treat moderate to severe rheumatoid arthritis. It helps decrease pain, tenderness, and swelling in the joints by reducing inflammation. It also helps slow the progression of bone and joint damage.

betrecep 5 mg

Request Callback

₹ 600 Get Latest Price

Strength5 mg
BrandPfizer
Manufacturerphyzer
Packaging Size56 Tablets
Packaging TypeBox
UsageRheumatoid arthritis, Psoriatic Arthritis
  • tofacitinib) is indicated for the treatment of adult patients with moderately to severely active rheumatoid arthritis who have had an inadequate response or intolerance to methotrexate. It may be used as monotherapy or in combination with methotrexate or other nonbiologic disease-modifying antirheumatic drugs (DMARDs).
  • Limitations of Use: Use of XELJANZ/XELJANZ XR in combination with biologic DMARDs or with potent immunosuppressants such as azathioprine and cyclosporine is not recommended.
X

Contact Us

Vipul Ahir (Partner)
HCX Pharmaceuticals LLP
Plot No-583, Varsha Co-Op HO Society Ltd-2, Varachha Road, Matawadi
Surat - 395006, Gujarat, India

Get Directions
Send Email
Share: